tiprankstipranks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
Holding ESLA?
Track your performance easily

Estrella Immunopharma (ESLA) Financial Statements

22 Followers

Estrella Immunopharma Financial Overview

Estrella Immunopharma's market cap is currently ―. The company's EPS TTM is $-0.243; its P/E ratio is ―; Estrella Immunopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 50.00K---
Gross Profit-$ 50.00K---
EBIT$ -3.38M$ -3.95M$ -469.53K-$ -1.87M
EBITDA$ -3.38M$ -3.95M$ -469.53K-$ -1.87M
Net Income Common Stockholders$ -3.38M$ -3.95M$ -469.53K-$ -1.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.80M$ 4.17M$ 4.73M$ 9.05M$ 22.14M
Total Assets$ 3.74M$ 4.45M$ 8.63M$ 9.45M$ 27.35M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 2.99M$ 180.70K$ 138.49K$ 398.73K$ 17.28M
Stockholders Equity$ 746.29K$ 4.27M$ 8.49M$ 9.05M$ 10.07M
Cash Flow-
Free Cash Flow$ -2.22M$ -291.51K$ -4.23M-$ -275.19K
Operating Cash Flow$ -2.22M$ -291.51K$ -4.23M$ -11.27M$ -275.19K
Investing Cash Flow---$ 5.07M$ -112.30K
Financing Cash Flow$ -150.47K$ -270.35K$ -84.09K$ -6.90M$ 20.05M
Currency in USD

Estrella Immunopharma Earnings and Revenue History

Estrella Immunopharma Debt to Assets

Estrella Immunopharma Cash Flow

Estrella Immunopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis